Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In the last 5 years Agnieszka Jakubowska conducts trials funded by: Eli Lilly, NewAmsterdam, and Novo Nordisk
Bader JL, Li FP, Olmstead PM, et al
Goal: Support metabolic efficiency through NNMT inhibition, potentially enhancing fat oxidation and NAD+ levels [1] [2]
Investigations include the relationship between IC/BPS, CP/CPPS and other chronic pain conditions (fibromyalgia, chronic fatigue syndrome, and IBS), innovative epidemiological studies, search for clinically important biomarkers, investigation of bacterial, viral and other infectious causative/exacerbating agents, novel brain imaging studies and animal studies to better understand the pathophysiology of these often disabling syndromes
Larger vials (15mg, 20mg, 30mg) offer slightly better per-mg pricing but require reconstitution volumes that may exceed optimal stability windows if not used quickly enough
